These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9245040)

  • 1. [Bone loss during low dose glucocorticoid treatment in patients with polymyalgia rheumatica. A double-blind, prospective comparison between prednisolone and deflazacort].
    Krogsgaard MR; Thamsborg G; Lund B
    Ugeskr Laeger; 1997 Jul; 159(30):4641-4. PubMed ID: 9245040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in bone mass during low dose corticosteroid treatment in patients with polymyalgia rheumatica: a double blind, prospective comparison between prednisolone and deflazacort.
    Krogsgaard MR; Thamsborg G; Lund B
    Ann Rheum Dis; 1996 Feb; 55(2):143-6. PubMed ID: 8712867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longterm prospective study of the equipotency between deflazacort and prednisolone in the treatment of patients with polymyalgia rheumatica.
    Krogsgaard MR; Lund B; Johnsson B
    J Rheumatol; 1995 Sep; 22(9):1660-2. PubMed ID: 8523341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deflazacort versus methylprednisolone in polymyalgia rheumatica: clinical equivalence and relative antiinflammatory potency of different treatment regimens.
    Di Munno O; Imbimbo B; Mazzantini M; Milani S; Occhipinti G; Pasero G
    J Rheumatol; 1995 Aug; 22(8):1492-8. PubMed ID: 7473472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
    Cacoub P; Chemlal K; Khalifa P; Wechsler B; De Gennes C; Belmatoug N; Cohen P; Ziza JM; Verdoncq B; Piette JC
    J Rheumatol; 2001 Nov; 28(11):2474-9. PubMed ID: 11708421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density and biochemical markers of bone metabolism in late onset rheumatoid arthritis and polymyalgia rheumatica--a prospective study on the influence of glucocorticoid therapy.
    Lange U; Boss B; Teichmann J; Stracke H; Neeck G
    Z Rheumatol; 2000; 59 Suppl 2():II/137-41. PubMed ID: 11155797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The deleterious effects of low-dose corticosteroids on bone density in patients with polymyalgia rheumatica.
    Pearce G; Ryan PF; Delmas PD; Tabensky DA; Seeman E
    Br J Rheumatol; 1998 Mar; 37(3):292-9. PubMed ID: 9566670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis.
    Messina OD; Barreira JC; Zanchetta JR; Maldonado-Cocco JA; Bogado CE; Sebastián ON; Flores D; Riopedre AM; Redondo G; Lázaro A
    J Rheumatol; 1992 Oct; 19(10):1520-6. PubMed ID: 1464862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort.
    Loftus J; Allen R; Hesp R; David J; Reid DM; Wright DJ; Green JR; Reeve J; Ansell BM; Woo PM
    Pediatrics; 1991 Sep; 88(3):428-36. PubMed ID: 1881719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of the relative antiinflammatory potency of deflazacort and prednisone in polymyalgia rheumatica.
    Lund B; Egsmose C; Jørgensen S; Krogsgaard MR
    Calcif Tissue Int; 1987 Dec; 41(6):316-20. PubMed ID: 3124940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl prednisolone in male inflammatory arthropathies: a 12-month open randomized pilot study.
    Saviola G; Abdi Ali L; Shams Eddin S; Coppini A; Cavalieri F; Campostrini L; Sacco S; Bucci M; Cirino G; Rossini M
    Rheumatology (Oxford); 2007 Jun; 46(6):994-8. PubMed ID: 17384176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment and diagnosis of polymyalgia rheumatica and temporal arteritis].
    Gran JT
    Tidsskr Nor Laegeforen; 2003 Dec; 123(23):3387. PubMed ID: 14713975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.
    Olgaard K; Storm T; van Wowern N; Daugaard H; Egfjord M; Lewin E; Brandi L
    Calcif Tissue Int; 1992 Jun; 50(6):490-7. PubMed ID: 1525702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized withdrawal of long-term prednisolone treatment in rheumatoid arthritis: effects on inflammation and bone mineral density.
    Tengstrand B; Larsson E; Klareskog L; Hafström I
    Scand J Rheumatol; 2007; 36(5):351-8. PubMed ID: 17963164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polymyalgia rheumatica and giant cell arteritis; diagnosis and side effects of low-dose long-term glucocorticoid therapy].
    Hatz HJ; Helmke K
    Z Rheumatol; 1992; 51(5):213-21. PubMed ID: 1476006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.
    Goffin E; Devogelaer JP; Lalaoui A; Depresseux G; De Naeyer P; Squifflet JP; Pirson Y; van Ypersele de Strihou C
    Transpl Int; 2002 Mar; 15(2-3):73-80. PubMed ID: 11935163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Does COPD affect bone mineral content?].
    Hens C; Böhning W
    Pneumologie; 1990 Feb; 44 Suppl 1():204-5. PubMed ID: 2114626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone density in myasthenia gravis patients receiving long-term prednisolone therapy.
    Wakata N; Nemoto H; Sugimoto H; Nomoto N; Konno S; Hayashi N; Araki Y; Nakazato A
    Clin Neurol Neurosurg; 2004 Mar; 106(2):139-41. PubMed ID: 15003307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term treatment of polymyalgia rheumatica with deflazacort.
    Cimmino MA; Moggiana G; Montecucco C; Caporali R; Accardo S
    Ann Rheum Dis; 1994 May; 53(5):331-3. PubMed ID: 8017988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of lymphocyte subpopulations in chronic autoimmune inflammatory rheumatic diseases. II. Polymyalgia rheumatica: behaviour of lymphocyte subpopulations during treatment with two different corticosteroids].
    Coaccioli S; Pinoca F; Giuliani M; Sabatini C; Puxeddu A
    Minerva Med; 2005 Oct; 96(5):379-87. PubMed ID: 16227953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.